[Aug 8, 2008]
Mylan on Wednesday announced a deal with Indian drug maker Famy Care to develop and sell 22 generic oral contraceptive products, the Pittsburgh Tribune-Review reports (Stouffer, Pittsburgh Tribune-Review, 8/7). Mylan plans to seek FDA approval for the products over the next few months and hopes to begin marketing them in 2010. Under the terms of the deal, Mylan can sell other contraceptives in other markets, including Australia and Japan. Mylan did not disclose financial terms of the deal (AP/Yahoo! News, 8/6).
The information contained in this publication reflects media coverage of women’s health issues and does not necessarily reflect the views of the National Partnership for Women & Families.
Search the Archives
Subscribe
Hot Topic
The greatest tribute we can pay Senator Kennedy is to redouble our efforts to see his vision for universal health care become reality.
So recommit yourself to one of the most important legislative challenges of our time.
Start by sharing your story!
Do you think we need health insurance reform, or is the status quo okay?
The Editors
Debra Ness, publisher & president, National Partnership
Laura Hessburg, associate editor & senior health policy advisor, National Partnership
Christine Monahan, assistant editor & health program assistant, National Partnership
Freya Riedlin, assistant editor & communications team, National Partnership
Francesca Tarant, assistant editor & communications team, National Partnership
Justyn Ware, editor
Amanda Wolfe, editor-in-chief
Brittany Hackett, senior writer
Cassandra Blohowiak, Audrey Horn, Julia Moss, Santosh Rao, Zach Swiss, Matt Wayt, staff writers
Tucker Ball, director of online marketing, National Partnership
